Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Interesting ... vote

<< Previous

Bullboard Posts

Next >>

Comment by MrMugsyon May 21, 2022 9:11am

127 Views

Post# 34700223

RE:Interesting ... vote

MrMugsy wrote: It looks like there were only 67 voters represented at the AGM this year. Those 67 people represent 54% of the shares. More to follow.

Looks like less people came out to vote this year - no more lockdown and people back to work?

In the past, saw 270 vote - representing 69% of the shares.

If we try to extrapolate from those numbers, best guess ... no more than 4,000-5,000 shareholders at this time.

Not many. IMO

<< Previous

Bullboard Posts

Next >>

Arbor Metals unearths encouraging results in lithium exploration